Alternative treatment for iron deficiency anemia: Irocbin versus Sherbat Faulad

The wide spread reason of anemia is Iron deficiency in Pakistan and even worldwide. A clinical trial was undertaken to assess the efficacy of Irocbin formulation for the treatment of iron deficiency anemia as compared to Sherbat Faulad. The curative evaluations of these medicines were recorded in cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pakistan journal of pharmaceutical sciences 2016-01, Vol.29 (1), p.157-164
Hauptverfasser: Ayaz, Sultan, Usmanghani, Khan, Nazar, Halima
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 164
container_issue 1
container_start_page 157
container_title Pakistan journal of pharmaceutical sciences
container_volume 29
creator Ayaz, Sultan
Usmanghani, Khan
Nazar, Halima
description The wide spread reason of anemia is Iron deficiency in Pakistan and even worldwide. A clinical trial was undertaken to assess the efficacy of Irocbin formulation for the treatment of iron deficiency anemia as compared to Sherbat Faulad. The curative evaluations of these medicines were recorded in clinically and biochemically identified cases of iron deficiency anemia. The therapeutic evaluation of the different drugs both test and control drug were conducted on the bases of improvement in the subjective signs and symptoms, clinical observations and biochemical investigations at periodic intervals during the course of therapy. This data was collected in the period November 2010 to November 2012 and completed the clinical trials. According to the statistical analysis comparison of data recorded by patients concerning to different variables, showed significant results between test and control groups (p
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762030409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A448441714</galeid><sourcerecordid>A448441714</sourcerecordid><originalsourceid>FETCH-LOGICAL-g278t-4e33ecf81798287cc3420cdb041d2adf17d02d89c52db645a3c28ee6fc9da1233</originalsourceid><addsrcrecordid>eNptkE9LAzEQxXNQbK1-BQl48bKSf91NvJVia6HQgwrelmwyWyO72ZpkC_32bmk9CDIDA4_fDG_eBRpTQmmWE_oxQtcxfhGSC6XUFRqxXB5bjdFm1iQIXie3B5wC6NSCT7juAnah89hC7YwDbw5Ye2idfsKr0JnKebyHEPuIXz8hVDrhhe4bbW_QZa2bCLfnOUHvi-e3-Uu23ixX89k627JCpkwA52BqSQslmSyM4YIRYysiqGXa1rSwhFmpzJTZKhdTzQ2TAHltlNWUcT5BD6e7u9B99xBT2bpooGkGl10fS1rkjHAiiBrQ-xO61Q2UztddCtoc8XImhBSCFlQM1OM_1FB2-Np0fshh0P8s3J0d9FULttwF1-pwKH-z5T9F9nNa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1762030409</pqid></control><display><type>article</type><title>Alternative treatment for iron deficiency anemia: Irocbin versus Sherbat Faulad</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ayaz, Sultan ; Usmanghani, Khan ; Nazar, Halima</creator><creatorcontrib>Ayaz, Sultan ; Usmanghani, Khan ; Nazar, Halima</creatorcontrib><description>The wide spread reason of anemia is Iron deficiency in Pakistan and even worldwide. A clinical trial was undertaken to assess the efficacy of Irocbin formulation for the treatment of iron deficiency anemia as compared to Sherbat Faulad. The curative evaluations of these medicines were recorded in clinically and biochemically identified cases of iron deficiency anemia. The therapeutic evaluation of the different drugs both test and control drug were conducted on the bases of improvement in the subjective signs and symptoms, clinical observations and biochemical investigations at periodic intervals during the course of therapy. This data was collected in the period November 2010 to November 2012 and completed the clinical trials. According to the statistical analysis comparison of data recorded by patients concerning to different variables, showed significant results between test and control groups (p&lt;0.05). By applying ANOVA test, the p values for multiple comparisons of the levels of improvement of Hemoglobin after treatment exhibited significant difference as compared Sherbat Faulad and Irocbin. The control drug Sherbat Faulad with only iron component improves Hemoglobin level and the sign and symptoms but associated with side adverse effects.</description><identifier>ISSN: 1011-601X</identifier><identifier>PMID: 26826829</identifier><language>eng</language><publisher>Pakistan: Pakistan Journal of Pharmaceutical Sciences</publisher><subject>Anemia, Iron-Deficiency - blood ; Anemia, Iron-Deficiency - drug therapy ; Comparative analysis ; Drug therapy ; Ferritins - blood ; Humans ; Iron deficiency anemia ; Medicinal plants ; Phytotherapy - adverse effects</subject><ispartof>Pakistan journal of pharmaceutical sciences, 2016-01, Vol.29 (1), p.157-164</ispartof><rights>COPYRIGHT 2016 Pakistan Journal of Pharmaceutical Sciences</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26826829$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ayaz, Sultan</creatorcontrib><creatorcontrib>Usmanghani, Khan</creatorcontrib><creatorcontrib>Nazar, Halima</creatorcontrib><title>Alternative treatment for iron deficiency anemia: Irocbin versus Sherbat Faulad</title><title>Pakistan journal of pharmaceutical sciences</title><addtitle>Pak J Pharm Sci</addtitle><description>The wide spread reason of anemia is Iron deficiency in Pakistan and even worldwide. A clinical trial was undertaken to assess the efficacy of Irocbin formulation for the treatment of iron deficiency anemia as compared to Sherbat Faulad. The curative evaluations of these medicines were recorded in clinically and biochemically identified cases of iron deficiency anemia. The therapeutic evaluation of the different drugs both test and control drug were conducted on the bases of improvement in the subjective signs and symptoms, clinical observations and biochemical investigations at periodic intervals during the course of therapy. This data was collected in the period November 2010 to November 2012 and completed the clinical trials. According to the statistical analysis comparison of data recorded by patients concerning to different variables, showed significant results between test and control groups (p&lt;0.05). By applying ANOVA test, the p values for multiple comparisons of the levels of improvement of Hemoglobin after treatment exhibited significant difference as compared Sherbat Faulad and Irocbin. The control drug Sherbat Faulad with only iron component improves Hemoglobin level and the sign and symptoms but associated with side adverse effects.</description><subject>Anemia, Iron-Deficiency - blood</subject><subject>Anemia, Iron-Deficiency - drug therapy</subject><subject>Comparative analysis</subject><subject>Drug therapy</subject><subject>Ferritins - blood</subject><subject>Humans</subject><subject>Iron deficiency anemia</subject><subject>Medicinal plants</subject><subject>Phytotherapy - adverse effects</subject><issn>1011-601X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE9LAzEQxXNQbK1-BQl48bKSf91NvJVia6HQgwrelmwyWyO72ZpkC_32bmk9CDIDA4_fDG_eBRpTQmmWE_oxQtcxfhGSC6XUFRqxXB5bjdFm1iQIXie3B5wC6NSCT7juAnah89hC7YwDbw5Ye2idfsKr0JnKebyHEPuIXz8hVDrhhe4bbW_QZa2bCLfnOUHvi-e3-Uu23ixX89k627JCpkwA52BqSQslmSyM4YIRYysiqGXa1rSwhFmpzJTZKhdTzQ2TAHltlNWUcT5BD6e7u9B99xBT2bpooGkGl10fS1rkjHAiiBrQ-xO61Q2UztddCtoc8XImhBSCFlQM1OM_1FB2-Np0fshh0P8s3J0d9FULttwF1-pwKH-z5T9F9nNa</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Ayaz, Sultan</creator><creator>Usmanghani, Khan</creator><creator>Nazar, Halima</creator><general>Pakistan Journal of Pharmaceutical Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>Alternative treatment for iron deficiency anemia: Irocbin versus Sherbat Faulad</title><author>Ayaz, Sultan ; Usmanghani, Khan ; Nazar, Halima</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g278t-4e33ecf81798287cc3420cdb041d2adf17d02d89c52db645a3c28ee6fc9da1233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anemia, Iron-Deficiency - blood</topic><topic>Anemia, Iron-Deficiency - drug therapy</topic><topic>Comparative analysis</topic><topic>Drug therapy</topic><topic>Ferritins - blood</topic><topic>Humans</topic><topic>Iron deficiency anemia</topic><topic>Medicinal plants</topic><topic>Phytotherapy - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ayaz, Sultan</creatorcontrib><creatorcontrib>Usmanghani, Khan</creatorcontrib><creatorcontrib>Nazar, Halima</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pakistan journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ayaz, Sultan</au><au>Usmanghani, Khan</au><au>Nazar, Halima</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative treatment for iron deficiency anemia: Irocbin versus Sherbat Faulad</atitle><jtitle>Pakistan journal of pharmaceutical sciences</jtitle><addtitle>Pak J Pharm Sci</addtitle><date>2016-01</date><risdate>2016</risdate><volume>29</volume><issue>1</issue><spage>157</spage><epage>164</epage><pages>157-164</pages><issn>1011-601X</issn><abstract>The wide spread reason of anemia is Iron deficiency in Pakistan and even worldwide. A clinical trial was undertaken to assess the efficacy of Irocbin formulation for the treatment of iron deficiency anemia as compared to Sherbat Faulad. The curative evaluations of these medicines were recorded in clinically and biochemically identified cases of iron deficiency anemia. The therapeutic evaluation of the different drugs both test and control drug were conducted on the bases of improvement in the subjective signs and symptoms, clinical observations and biochemical investigations at periodic intervals during the course of therapy. This data was collected in the period November 2010 to November 2012 and completed the clinical trials. According to the statistical analysis comparison of data recorded by patients concerning to different variables, showed significant results between test and control groups (p&lt;0.05). By applying ANOVA test, the p values for multiple comparisons of the levels of improvement of Hemoglobin after treatment exhibited significant difference as compared Sherbat Faulad and Irocbin. The control drug Sherbat Faulad with only iron component improves Hemoglobin level and the sign and symptoms but associated with side adverse effects.</abstract><cop>Pakistan</cop><pub>Pakistan Journal of Pharmaceutical Sciences</pub><pmid>26826829</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1011-601X
ispartof Pakistan journal of pharmaceutical sciences, 2016-01, Vol.29 (1), p.157-164
issn 1011-601X
language eng
recordid cdi_proquest_miscellaneous_1762030409
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Anemia, Iron-Deficiency - blood
Anemia, Iron-Deficiency - drug therapy
Comparative analysis
Drug therapy
Ferritins - blood
Humans
Iron deficiency anemia
Medicinal plants
Phytotherapy - adverse effects
title Alternative treatment for iron deficiency anemia: Irocbin versus Sherbat Faulad
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T12%3A11%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20treatment%20for%20iron%20deficiency%20anemia:%20Irocbin%20versus%20Sherbat%20Faulad&rft.jtitle=Pakistan%20journal%20of%20pharmaceutical%20sciences&rft.au=Ayaz,%20Sultan&rft.date=2016-01&rft.volume=29&rft.issue=1&rft.spage=157&rft.epage=164&rft.pages=157-164&rft.issn=1011-601X&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA448441714%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1762030409&rft_id=info:pmid/26826829&rft_galeid=A448441714&rfr_iscdi=true